PharmaCyte Biotech’s (OTCMKTS:PMCB) To Validate Its Cell-In-A-Box Encapsulation Technology

PharmaCyte Biotech’s (OTCMKTS:PMCB) To Validate Its Cell-In-A-Box Encapsulation Technology

PharmaCyte Biotech’s (OTCMKTS:PMCB) encapsulation technology could soon transform the treatment and management of difficult-to-treat diseases.  The company is nearing the second phase of clinical evaluation in locally advanced pancreatic cancer, which will give patients hope by shrinking tumors for easier surgical removal.  PharmaCyte to test its Cell-in-a-Box tech Usually, clinical trials are very important in […]Published at Fri, 08 Nov 2019 05:53:11 +0000

Post a Comment

Your email address will not be published. Required fields are marked *

*